A double blind Placebo Controlled randomised Trial of Adalimumab in the treatment of Hidradenitis Suppurativa
British Journal of Dermatology, 04/04/2011Miller I et al.
A significant reduction was seen in Sartorius after 6 weeks and an almost significant reduction was seen after 12 weeks of active treatment when compared to the placebo–group. Significant reduction in Hidradenitis Suppurativa severity was gained after 6 weeks. No long–term curative effect was uniformly seen.
In this pilot randomised clinical trial we present further evidence supporting the efficacy of TNF alpha blockage in hidradenitis suppurativa
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.